STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news

CryptoAlerta — análise de criptomoedas e mercado em tempo real